• Info
  • Insider Ownership

Insider Trading & Ownership of Athyrium Opportunities IV Acquisition 2 LP

Location
New York, NY
Summary
The estimated value of insider holdings of Athyrium Opportunities IV Acquisition 2 LP is at least $201,290 dollars as of 12 Aug 2022. Athyrium Opportunities IV Acquisition 2 LP is the 10%+ Owner of RVL Pharmaceuticals plc and owns shares of RVL Pharmaceuticals plc stock worth about $201.3K.
Signature
/s/ Athyrium Opportunities IV Acquisition 2 LP, by Athyrium Opportunities Associates IV LP, its General Partner, by Athyrium Opportunities Associates IV GP LLC, its General Partner, by Andrew Hyman, Senior Vice President, Secretary
All Insider Reports
All Insider Reports

Notify me when Athyrium Opportunities IV Acquisition 2 LP files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Athyrium Opportunities IV Acquisition 2 LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
RVLP RVL Pharmaceuticals plc 10%+ Owner $201,290 08 Aug 2022

There are no insider transactions reported by Athyrium Opportunities IV Acquisition 2 LP